Florence Bichat
Research Subjects
Florence Bichat has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Frédéric Chagué
University Hospital Center, Cardiology, Dijon, France
7 shared publications - Yves Cottin
Dijon Bourgogne University Hospital, Cardiology Department, PEC2 ER 7460, Bourgogne Europe University , 1 boulevard Jeanne d'Arc, 21000 Dijon
7 shared publications - Marianne Zeller
Physiopathologie et Epidémiologie Cérébro-Cardiovasculaire (PEC2), EA 7460, Université Bourgogne Europe, UFR des sciences de santé , 7 Bd Jeanne d’Arc, Dijon 21000
6 shared publications - Maud Maza
Cardiology Department, CHU Dijon Bourgogne
4 shared publications A Cransac-Miet
University Hospital Center, Pharmacy, Dijon, France
3 shared publicationsA Soudry
University Hospital Center, Clinical Research, Dijon, France
3 shared publications
Latest Publications
- Open Access
- 10 November 2023
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 18 (1) , e38-e43
Characteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17-year period
- 10 November 2023
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 18 (1) , e38-e43
Open AccessCharacteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17-year period
- 29 September 2023
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 116 (12) , 597-601
History of illicit drug use in adults with acute myocardial infarction: Temporal trends from the French national hospital discharge database
- 29 September 2023
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 116 (12) , 597-601
History of illicit drug use in adults with acute myocardial infarction: Temporal trends from the French national hospital discharge database
- Open Access
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Elevated levels of Lp(a) are associated with coronary lesion complexity in patients hospitalized for an acute myocardial infarction: data from the French RICO Survey
Background: Although patients with elevated Lp(a) are at high risk of acute myocardial infarction (MI), coronary artery disease (CAD) burden associated with Lp(a) remains poorly investigated. Methods: Single center study including all consecutive patients hospitalized for an acute MI in Coronary Care Unit from the RICO database (2019–2021) who underwent coronary angiography and blood sample for Lp(a) assessment on admission. Coronary lesion complexity was retrospectively assessed by SYNTAX score and pre-specified angiographic criteria. Patients were compared according to their Lp(a) levels: 100 mg/dL (very high). Results: 921 patients were included, of whom 177 (19.2%) had elevated Lp(a) >50 mg/dL, including 121 (13.1%) with high and 56 (6.1%) with very high Lp(a). Median (IQR) age was similar across the 3 groups (normal: 68 (58–78)y; high: 70 (60–80)y; very high: 69 (61–78)y, p=0.381). When compared with patients with normal Lp(a), patients with high and very high Lp(a) levels had increased prevalence of personal history of CAD (19%, 28% and 29%, respectively, p=0.026) and family history of CAD (19%, 26% and 29%, p=0.032, respectively). The rate of women was more common in very high Lp(a) level than in high and normal groups (46%, 33%, and 29%, respectively, p=0.016). Rate of ST-segment elevation MI was similar for the 3 groups (p=0.961). At coronary angiography, CAD burden, as assessed by SYNTAX score was much higher in elevated Lp(a) groups (11 (6–19), 15 (8–24), 17 (7–25), p=0.001, respectively). Moreover, patients with elevated Lp(a) had more complex coronary lesions (p=0.034), characterized by left main (p=0.021), and calcified lesions (p=0.002) (figure). In-hospital mortality gradually increased across the 3 groups (2.8%, 6.6%, 8.9%, p=0.010, respectively). Conclusions: This retrospective study in patients with acute MI shows that elevated Lp(a) were common, associated with high risk for in-hospital mortality. Patients with high Lp(a) were characterized by severe CAD burden, with complex anatomy features including left main and calcified lesions. The long-term prognostic impact of Lp(a)-associated CAD burden needs to be explored. Funding Acknowledgement: Type of funding sources: Public Institution(s). Main funding source(s): ARS Bourgogne Franche ComtéCHU Dijon BourgogneAssociation de Cardiologie de Bourgogne
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Open AccessElevated levels of Lp(a) are associated with coronary lesion complexity in patients hospitalized for an acute myocardial infarction: data from the French RICO Survey
Background: Although patients with elevated Lp(a) are at high risk of acute myocardial infarction (MI), coronary artery disease (CAD) burden associated with Lp(a) remains poorly investigated. Methods: Single center study including all consecutive patients hospitalized for an acute MI in Coronary Care Unit from the RICO database (2019–2021) who underwent coronary angiography and blood sample for Lp(a) assessment on admission. Coronary lesion complexity was retrospectively assessed by SYNTAX score and pre-specified angiographic criteria. Patients were compared according to their Lp(a) levels: 100 mg/dL (very high). Results: 921 patients were included, of whom 177 (19.2%) had elevated Lp(a) >50 mg/dL, including 121 (13.1%) with high and 56 (6.1%) with very high Lp(a). Median (IQR) age was similar across the 3 groups (normal: 68 (58–78)y; high: 70 (60–80)y; very high: 69 (61–78)y, p=0.381). When compared with patients with normal Lp(a), patients with high and very high Lp(a) levels had increased prevalence of personal history of CAD (19%, 28% and 29%, respectively, p=0.026) and family history of CAD (19%, 26% and 29%, p=0.032, respectively). The rate of women was more common in very high Lp(a) level than in high and normal groups (46%, 33%, and 29%, respectively, p=0.016). Rate of ST-segment elevation MI was similar for the 3 groups (p=0.961). At coronary angiography, CAD burden, as assessed by SYNTAX score was much higher in elevated Lp(a) groups (11 (6–19), 15 (8–24), 17 (7–25), p=0.001, respectively). Moreover, patients with elevated Lp(a) had more complex coronary lesions (p=0.034), characterized by left main (p=0.021), and calcified lesions (p=0.002) (figure). In-hospital mortality gradually increased across the 3 groups (2.8%, 6.6%, 8.9%, p=0.010, respectively). Conclusions: This retrospective study in patients with acute MI shows that elevated Lp(a) were common, associated with high risk for in-hospital mortality. Patients with high Lp(a) were characterized by severe CAD burden, with complex anatomy features including left main and calcified lesions. The long-term prognostic impact of Lp(a)-associated CAD burden needs to be explored. Funding Acknowledgement: Type of funding sources: Public Institution(s). Main funding source(s): ARS Bourgogne Franche ComtéCHU Dijon BourgogneAssociation de Cardiologie de Bourgogne
- Open Access
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
Smoking and associated unhealthy lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 related lockdown
Funding Acknowledgements: Type of funding sources: Public hospital(s). Main funding source(s): Dijon University Hospital France OnBehalf: CLEO-CD Background: Lockdown can affect tobacco smoking (TS) behaviours. Purpose: To evaluate the impact of lockdown on (TS) and associated lifestyle behaviours in patients with Chronic coronary syndrome (CCS) and congestive heart failure (CHF) Methods: CCS and CHF patients were invited to answer to a phone-call questionnaire during the 1st COVID-19 lockdown start Results: (Table) 343 questionnaires were fit for analysis, 43 (12.5%) were current smokers (CS). CS were younger (p < 0.001), none stopped and 13 increased their consumption (main reasons were stress and boredom). CS felt more often cramped (p = 0.023). CS who increased their TS consumption showed a trend toward a higher rate of unhealthy lifestyle behaviours Conclusions: During the lockdown, more than ¼ of CS with CCS or CHF increased their TS consumption and none quitted. Moreover, TS was often associated with other deleterious behaviours increasing their risk for short and long term Main results Total Non-Smokers Smokers p* N(%) 344 301 43 Age, years 67.7 ± 12.8 69.2 ± 12.2 57.2 ± 12.1 <0.001 Men/Women 229/115 197/104 32/11 0.300 CCS/CHF 220/124 185/116 36/7 0.004 Urban/Rural 163/181 137/164 26/17 0.073 Living alone at home 83(24.3) 68(22.7) 15(34.9) 0.089 COVID screening (PCR) 11(3.2) 7(2.3) 4(9.3) 0.037 Feeling cramped 19(5.5) 13(4.4) 6(14.0) 0.023 Feeling less well 75(21.9) 65(21.7) 10(23.8) 0.842 K6 ≥ 5 81(23.7) 70(23.5) 11(25.6) 0.845 Physical activity decrease 146(42.6) 125(42.1) 21(48.8) 0.323 Screen time increase 154(45.0) 130(43.5) 24(55.8) 0.100 Alcohol consumption increase 14(5.5) 11(4.9) 3(7.5) 0.419 Sleep change 83(24.6) 68(22.5) 15(39.5) 0.083 Weight increase 77(22.4) 64(21.3) 13(30.2) 0.242 Smokers (n = 43) Smoking increase No smoking increase p** Feeling less well 5(38.5) 5(17.2) 0.238 Screen time increase 10(76.9) 14(46.7) 0.104 Weight increase 6(46.2) 7(23.3) 0.173 n(%) or mean ± SD. *p value: Smokers vs non smokers. **p value: Smoking increase vs no smoking increase
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
Open AccessSmoking and associated unhealthy lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 related lockdown
Funding Acknowledgements: Type of funding sources: Public hospital(s). Main funding source(s): Dijon University Hospital France OnBehalf: CLEO-CD Background: Lockdown can affect tobacco smoking (TS) behaviours. Purpose: To evaluate the impact of lockdown on (TS) and associated lifestyle behaviours in patients with Chronic coronary syndrome (CCS) and congestive heart failure (CHF) Methods: CCS and CHF patients were invited to answer to a phone-call questionnaire during the 1st COVID-19 lockdown start Results: (Table) 343 questionnaires were fit for analysis, 43 (12.5%) were current smokers (CS). CS were younger (p < 0.001), none stopped and 13 increased their consumption (main reasons were stress and boredom). CS felt more often cramped (p = 0.023). CS who increased their TS consumption showed a trend toward a higher rate of unhealthy lifestyle behaviours Conclusions: During the lockdown, more than ¼ of CS with CCS or CHF increased their TS consumption and none quitted. Moreover, TS was often associated with other deleterious behaviours increasing their risk for short and long term Main results Total Non-Smokers Smokers p* N(%) 344 301 43 Age, years 67.7 ± 12.8 69.2 ± 12.2 57.2 ± 12.1 <0.001 Men/Women 229/115 197/104 32/11 0.300 CCS/CHF 220/124 185/116 36/7 0.004 Urban/Rural 163/181 137/164 26/17 0.073 Living alone at home 83(24.3) 68(22.7) 15(34.9) 0.089 COVID screening (PCR) 11(3.2) 7(2.3) 4(9.3) 0.037 Feeling cramped 19(5.5) 13(4.4) 6(14.0) 0.023 Feeling less well 75(21.9) 65(21.7) 10(23.8) 0.842 K6 ≥ 5 81(23.7) 70(23.5) 11(25.6) 0.845 Physical activity decrease 146(42.6) 125(42.1) 21(48.8) 0.323 Screen time increase 154(45.0) 130(43.5) 24(55.8) 0.100 Alcohol consumption increase 14(5.5) 11(4.9) 3(7.5) 0.419 Sleep change 83(24.6) 68(22.5) 15(39.5) 0.083 Weight increase 77(22.4) 64(21.3) 13(30.2) 0.242 Smokers (n = 43) Smoking increase No smoking increase p** Feeling less well 5(38.5) 5(17.2) 0.238 Screen time increase 10(76.9) 14(46.7) 0.104 Weight increase 6(46.2) 7(23.3) 0.173 n(%) or mean ± SD. *p value: Smokers vs non smokers. **p value: Smoking increase vs no smoking increase
- Open Access
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
Impact of lockdown in patients with congestive heart failure during the Covid-19 pandemic
Funding Acknowledgements: Type of funding sources: Private company. Main funding source(s): Dijon Football Côte d"Or OnBehalf: CLEO-CD Background: Congestive heart failure (CHF) can be destabilized by Covid-19 (C19) lockdown. Purpose: To evaluate the impact of lockdown in CHF patients. Methods: 150 out-patients from the HF Clinic of our hospital were invited to answer to a phone-call interview during the 7th week of first C19 lockdown . Results: From 124 questionnaires, more than 1/5 felt worse and almost 1/4 declared a psychologic distress. CHF medications were modified in 10%. Decrease in physical activity was observed in 2/5. Almost 1/2 declared increased screen time; smokers often increased consumption. Adherence to dietary counselling was reduced by 1/6, increase in weight and HF symptoms were common. Some patients benefitted from a teleconsultation. Conclusions: Our patients exhibited well-being impairment and unhealthy behaviours. Medication adherence was not diminished and the reduction in care access was counterbalanced by a switch toward telehealth. Main results 124 patients 75 Male (M) 49 Female (F) p value between M and F Age, years 71.0 ± 14.0 68.9 ± 13.7 74.3 ± 14.0 0.03 Urban/Rural 82/42 49/26 33/16 0.84 HFrEF* 87 62 25 <0.001 Dilated cardiomyopathy 50 37 13 0.02 Ischemic 23 18 5 0.06 Other 51 20 31 <0.0001 Current NYHA class I/II/III/IV 39/48/28/9 29/29/14/3 10/19/14/6 0.66 History of NYHA III-IV class 94 62 32 0.03 Electronic device/Telemonitoring 77/28 54/18 23/10 2 kg 34 22 (29.3) 12 0.68 Switch for teleconsultation (##) 16 11 (34.4) 5 1 Teleconsultation (total) 23 14 9 1 Decrease in physical activity 52 25 (33.3) 27 0.02 Increase in screen time 57 31 (41.3) 26 0.27 Increase in cigarette consumption (9 smokers) 4 3 1 1 Decrease in dietary adherence (###) 22 (17.7) 15 (20.0) 7 (14.3) 0.47 *HFrEF; # Kessler-6 score ≥ 5; ## from planned physical examination; ### salt, water, alcohol
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
Open AccessImpact of lockdown in patients with congestive heart failure during the Covid-19 pandemic
Funding Acknowledgements: Type of funding sources: Private company. Main funding source(s): Dijon Football Côte d"Or OnBehalf: CLEO-CD Background: Congestive heart failure (CHF) can be destabilized by Covid-19 (C19) lockdown. Purpose: To evaluate the impact of lockdown in CHF patients. Methods: 150 out-patients from the HF Clinic of our hospital were invited to answer to a phone-call interview during the 7th week of first C19 lockdown . Results: From 124 questionnaires, more than 1/5 felt worse and almost 1/4 declared a psychologic distress. CHF medications were modified in 10%. Decrease in physical activity was observed in 2/5. Almost 1/2 declared increased screen time; smokers often increased consumption. Adherence to dietary counselling was reduced by 1/6, increase in weight and HF symptoms were common. Some patients benefitted from a teleconsultation. Conclusions: Our patients exhibited well-being impairment and unhealthy behaviours. Medication adherence was not diminished and the reduction in care access was counterbalanced by a switch toward telehealth. Main results 124 patients 75 Male (M) 49 Female (F) p value between M and F Age, years 71.0 ± 14.0 68.9 ± 13.7 74.3 ± 14.0 0.03 Urban/Rural 82/42 49/26 33/16 0.84 HFrEF* 87 62 25 <0.001 Dilated cardiomyopathy 50 37 13 0.02 Ischemic 23 18 5 0.06 Other 51 20 31 <0.0001 Current NYHA class I/II/III/IV 39/48/28/9 29/29/14/3 10/19/14/6 0.66 History of NYHA III-IV class 94 62 32 0.03 Electronic device/Telemonitoring 77/28 54/18 23/10 2 kg 34 22 (29.3) 12 0.68 Switch for teleconsultation (##) 16 11 (34.4) 5 1 Teleconsultation (total) 23 14 9 1 Decrease in physical activity 52 25 (33.3) 27 0.02 Increase in screen time 57 31 (41.3) 26 0.27 Increase in cigarette consumption (9 smokers) 4 3 1 1 Decrease in dietary adherence (###) 22 (17.7) 15 (20.0) 7 (14.3) 0.47 *HFrEF; # Kessler-6 score ≥ 5; ## from planned physical examination; ### salt, water, alcohol
- Open Access
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
During the Covid-19 lockdown, rural residence is associated to healthier lifestyle behaviours in patients with chronic coronary syndrom
Funding Acknowledgements: Type of funding sources: Private company. Main funding source(s): Dijon Football Côte d"Or OnBehalf: CLEO-CD Background: Lifestyle behaviours (LB) are keystones of coronary prevention and might be impacted during Covid-19 (C19) lockdown. Purpose: To compare the LB in urban and rural patients suffering from chronic coronary syndrom (CCS) Methods: 250 outpatients suffering from CCS were invited during the 6th week of the 1st C19 lockdown to answer to a phone-call questionnaire. Results: 220 questionnaires were fit for analysis, of whom about 1/4 declared a psychologic impairment; people staying at home in urban zones trended to be more impacted. Unhealthier behaviours including cigarette smoking, decrease in physical activity and increase in screentime were common, especially in patients from urban zones. Telehealth partially counterbalanced limitation in care access and none declared discontinuation of medications. Conclusion: The lockdown impacted wellbeing of CCS patients; living in rural zone was associated with a healthier LB. Main results TOTAL URBAN RURAL N (%) 220 107 113 p * Age (years, SD) 66.4+/-12.0 64.5+/-14.0 68.2+/-9.5 0.02 Male/Female 154/66 76/31 78/35 0.77 Alone at home 47(21.7) 28(26.2) 19(17.3) 0.13 Feeling cramped 16(7.6) 13(12.5) 3(2.8) 0.008 Feeling less well 50(22.9) 29(27.1) 21(18.9) 0.19 Kessler-6 score ≥ 5 57(26.8) 33(32.0) 24(21.8)) 0.12 Sleep impairment 53(24.5) 30(28.6) 23(20.7) 0.20 Angina pectorisdestabilization 13(6.6) 8(7.9) 5(5.3) 0.57 Cancelled physical examination** 67(63.8) 40(65.6) 27(61.4) 0.68 Switched to Telehealth*** 16(17.0) 7(17.5) 9(16.7) 1 Coronavirus testing 7(3.2) 3(2.8) 4(3.6) 1 Lifestyle behaviours Cigarette smoking 36(16.4) 26(23.3) 10(9.3) 0.006 Cigarette smoking increase 11(30.6) 8(40.0) 3(18.8) 0.27 Decreased physical activity 96(44.2) 56(53.3) 40(35.7) 0.009 Screentime increase 98(45.0) 59(55.1) 39(35.1) 0.004 Alcohol intake increase 10(5.2) 5(5.3) 5(5.2) 1 Weight increase ≥ 2 kg 52(24.5) 28(26.9) 24(22.2) 0.52 * between Urban and Rural **from scheduled physical examination ***from cancelled scheduled physical examination
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
Open AccessDuring the Covid-19 lockdown, rural residence is associated to healthier lifestyle behaviours in patients with chronic coronary syndrom
Funding Acknowledgements: Type of funding sources: Private company. Main funding source(s): Dijon Football Côte d"Or OnBehalf: CLEO-CD Background: Lifestyle behaviours (LB) are keystones of coronary prevention and might be impacted during Covid-19 (C19) lockdown. Purpose: To compare the LB in urban and rural patients suffering from chronic coronary syndrom (CCS) Methods: 250 outpatients suffering from CCS were invited during the 6th week of the 1st C19 lockdown to answer to a phone-call questionnaire. Results: 220 questionnaires were fit for analysis, of whom about 1/4 declared a psychologic impairment; people staying at home in urban zones trended to be more impacted. Unhealthier behaviours including cigarette smoking, decrease in physical activity and increase in screentime were common, especially in patients from urban zones. Telehealth partially counterbalanced limitation in care access and none declared discontinuation of medications. Conclusion: The lockdown impacted wellbeing of CCS patients; living in rural zone was associated with a healthier LB. Main results TOTAL URBAN RURAL N (%) 220 107 113 p * Age (years, SD) 66.4+/-12.0 64.5+/-14.0 68.2+/-9.5 0.02 Male/Female 154/66 76/31 78/35 0.77 Alone at home 47(21.7) 28(26.2) 19(17.3) 0.13 Feeling cramped 16(7.6) 13(12.5) 3(2.8) 0.008 Feeling less well 50(22.9) 29(27.1) 21(18.9) 0.19 Kessler-6 score ≥ 5 57(26.8) 33(32.0) 24(21.8)) 0.12 Sleep impairment 53(24.5) 30(28.6) 23(20.7) 0.20 Angina pectorisdestabilization 13(6.6) 8(7.9) 5(5.3) 0.57 Cancelled physical examination** 67(63.8) 40(65.6) 27(61.4) 0.68 Switched to Telehealth*** 16(17.0) 7(17.5) 9(16.7) 1 Coronavirus testing 7(3.2) 3(2.8) 4(3.6) 1 Lifestyle behaviours Cigarette smoking 36(16.4) 26(23.3) 10(9.3) 0.006 Cigarette smoking increase 11(30.6) 8(40.0) 3(18.8) 0.27 Decreased physical activity 96(44.2) 56(53.3) 40(35.7) 0.009 Screentime increase 98(45.0) 59(55.1) 39(35.1) 0.004 Alcohol intake increase 10(5.2) 5(5.3) 5(5.2) 1 Weight increase ≥ 2 kg 52(24.5) 28(26.9) 24(22.2) 0.52 * between Urban and Rural **from scheduled physical examination ***from cancelled scheduled physical examination
- 1 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (Supplement)
P4550Growth differentiation factor 15 as an integrative biomarker of heart failure in patients with acute myocardial infarction
Background: Growth differentiation factor 15 (GDF15), a stress-responsive cytokine member of the transforming growth factor-β family, is an emerging biomarker in cardiovascular (CV) diseases. GDF15 is weakly expressed in normal condition but increased in pathological situations such as inflammation, oxidative stress, and left ventricular remodeling. Recent data suggest GDF15 as a marker in heart failure (HF). Purpose: We aimed to identify the determinants of GDF15 circulating levels in patients admitted for an acute myocardial infarction (AMI). Methods: In our prospective study, all consecutive patients admitted from June 2016 to February 2018 for type 1 AMI in the Coronary Care unit from our University Hospital were included. Chronic HF patients were excluded. In-hospital severe HF was defined as killip class>2. Blood samples were taken on admission and serum levels of GDF15 were measured using a commercially available ELISA kit. Results: Among the 284 AMI patients, median age was at 67 (57–78) y, 27% were women, 23% had diabetes and 59% were hypertensive. GDF15 levels (median = 1,144 (775–1,891) ng/L were strongly correlated with age (r=0.493, p<0.001), and elevated with most CV risk factors (i.e. hypertension, diabetes), prior CAD, chronic kidney disease (p3 mg/L (p5,000 ng/L [OR: 8.43; 95% CI (1.57–45.32)] is as independent estimate of HF, beyond age and other confounding (i.e. admission systolic blood pressure, LVEF and Log N-terminal pro-Brain Natriuretic Peptide). GDF15 levels according to HF development Conclusions: These preliminary results suggest that GDF15 could be an integrative biomarker of severe HF in patient with AMI. Further studies are needed to elucidate the underlying mechanisms linking the cytokine with the development of HF.
- 1 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (Supplement)
P4550Growth differentiation factor 15 as an integrative biomarker of heart failure in patients with acute myocardial infarction
Background: Growth differentiation factor 15 (GDF15), a stress-responsive cytokine member of the transforming growth factor-β family, is an emerging biomarker in cardiovascular (CV) diseases. GDF15 is weakly expressed in normal condition but increased in pathological situations such as inflammation, oxidative stress, and left ventricular remodeling. Recent data suggest GDF15 as a marker in heart failure (HF). Purpose: We aimed to identify the determinants of GDF15 circulating levels in patients admitted for an acute myocardial infarction (AMI). Methods: In our prospective study, all consecutive patients admitted from June 2016 to February 2018 for type 1 AMI in the Coronary Care unit from our University Hospital were included. Chronic HF patients were excluded. In-hospital severe HF was defined as killip class>2. Blood samples were taken on admission and serum levels of GDF15 were measured using a commercially available ELISA kit. Results: Among the 284 AMI patients, median age was at 67 (57–78) y, 27% were women, 23% had diabetes and 59% were hypertensive. GDF15 levels (median = 1,144 (775–1,891) ng/L were strongly correlated with age (r=0.493, p<0.001), and elevated with most CV risk factors (i.e. hypertension, diabetes), prior CAD, chronic kidney disease (p3 mg/L (p5,000 ng/L [OR: 8.43; 95% CI (1.57–45.32)] is as independent estimate of HF, beyond age and other confounding (i.e. admission systolic blood pressure, LVEF and Log N-terminal pro-Brain Natriuretic Peptide). GDF15 levels according to HF development Conclusions: These preliminary results suggest that GDF15 could be an integrative biomarker of severe HF in patient with AMI. Further studies are needed to elucidate the underlying mechanisms linking the cytokine with the development of HF.
- 1 April 2019
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 11 (1) , e299-e300
More than 50% of non-healing at one year in “infarct-like” acute myocarditis evaluated by Cardiac Magnetic Resonance
- 1 April 2019
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 11 (1) , e299-e300
More than 50% of non-healing at one year in “infarct-like” acute myocarditis evaluated by Cardiac Magnetic Resonance